TITLE

ANAGRELIDE

PUB. DATE
January 2008
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p34
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on anagrelide which is used for the treatment of diseases related to blood platelets. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug with other drugs is also mentioned.
ACCESSION #
31714896

 

Related Articles

  • ANAGRELIDE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p32 

    The article presents information on anagrelide, a drug developed to reduce elevated platelet count and the risk of thrombosis, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • ANAGRELIDE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p30 

    The article presents information on anagrelide, a drug developed to reduce increased platelet counts and the risk of thrombosis, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • ANAGRELIDE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p34 

    The article presents information on agrylin which is used for the treatment of diseases related to blood platelets. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug...

  • Patients with ⩾ 20 x 109/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience. Baldini, Simone; Rigacci, Luigi; Carrai, Valentina; Alterini, Renato; Fjerza, Rajmonda; Bosi, Alberto // Mediterranean Journal of Hematology & Infectious Diseases;2012, Vol. 4 Issue 1, p1 

    Patients with chronic immune thrombocytopenia treated with romiplostim may benefit from a higher starting dose when a rapid increase in count is needed, but it could be avoided in those with a prompt response to the standard dosage. We hypothesized that a platelet count ⩾ 20 × 109/l at...

  • Safety of the Thrombopoiesis-Stimulating Agents for the Treatment of Immune Thrombocytopenia. Cuker, Adam; Chiang, Elaine Y.; Cines, Douglas B. // Current Drug Safety;Apr2010, Vol. 5 Issue 2, p171 

    The thrombopoiesis-stimulating agents (TSAs) are a novel class of drugs for the treatment of chronic immune thrombocytopenia (ITP). Roimplostim and eltrombopag, the first two TSAs to enter clinical use, received regulatory approval in 2008 and stand poised to change the treatment paradigm in...

  • Levetiracetam.  // Reactions Weekly;10/17/2009, Issue 1274, p26 

    The article describes the case of a 75-year-old man who developed platelet dysfunction while receiving treatment with levetiracetam for focal motor seizures. Particular focus is given to his medical history and dosing regimen. A defect in thromboxane-dependent platelet activation and aggregation...

  • BISMUTH SALTS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p190 

    The article presents information on bismuth salts, an antidiarrheal, antacid drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • DRONABINOL (THC, Marijuana).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p350 

    The article presents information on antiemetic drug dronabinol, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs and substances.

  • DRONABINOL (THC, Marijuana).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p350 

    The article presents information on antiemetic drug dronabinol, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs and substances.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics